Temprian Oncology Incorporated

Temprian Oncology Incorporated

Pharmaceutical Manufacturing

A drug development startup fighting melanoma through MBEH Nanoparticles.

About us

Temprian Oncology Incorporated is a Northwestern University Spinoff capitalizing on the innovations of Dr. Caroline Le Poole, Professor of Dermatology, Microbiology and Immunology at the NU Feinberg School of Medicine and Dr. SonBinh T. Nguyen, Professor, Department of Chemistry at the NU Weinberg College of Arts and Sciences. The company develops an MBEH-Nanoparticle based drug to fight metastasized melanoma.

Industry
Pharmaceutical Manufacturing
Company size
2-10 employees
Type
Privately Held
Founded
2023
Specialties
Nanoparticles, Melanoma Treatment, MBEH, Lauroyl MBEH, Cancer research, and Immunetherapy

Employees at Temprian Oncology Incorporated

Updates

Similar pages